SEC Form 3 · accession 0001193125-26-333385
Attovia Therapeutics, Inc. · ATTO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Angie You
Director
Period of report
Aug 4, 2026
Accepted (ET)
Aug 4, 2026 · 7:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0002058707
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 52,852 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $4.9237 | holding | — | — | — | — | May 17, 2035 | Common Stock | 19,913 | — | D |
Explanation of responses
- F1The option vests over a three-year period. The vesting schedule is as follows: 33% vested on June 29, 2025, an additional 33% vested on June 29, 2026, and the final 33% shall vest on July 29, 2027, subject to reporting person's continued service to the Issuer on each vesting date.
- F2The option vests over a three-year period. The vesting schedule is as follows: 33% vested on May 18, 2026, an additional 33% shall vest on May 18, 2027, and the final 33% shall vest on May 18, 2028, subject to the reporting person's continued service to the Issuer on each vesting date.
Remarks
Exhibit 24.1